Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Healthy

Interventions

DRUG

JNJ-56021927 60 Milligram

JNJ-56021927 60 mg oral tablet.

DRUG

JNJ-56021927 120 Milligram

JNJ-56021927 120 mg as 2 tablets of 60 mg.

DRUG

JNJ-56021927 240 Milligram

JNJ-56021927 240 mg as 4 tablets of 60 mg.

Trial Locations (1)

Kumamoto